Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
EFFECT OF CPAP THERAPY ON DAYTIME FUNCTION IN PATIENTS WITH MILD SLEEP APNOEA HYPOPNOEA SYNDROME/
Autore:
ENGLEMAN HM; MARTIN SE; DEARY IJ; DOUGLAS NJ;
Indirizzi:
ROYAL INFIRM,SCOTTISH NATL SLEEP LAB,LAUSITON PL EDINBURGH EH3 9YW MIDLOTHIAN SCOTLAND UNIV EDINBURGH,RESP MED UNIT EDINBURGH EH8 9YL MIDLOTHIAN SCOTLAND UNIV EDINBURGH,DEPT PSYCHOL EDINBURGH EH8 9YL MIDLOTHIAN SCOTLAND
Titolo Testata:
Thorax
fascicolo: 2, volume: 52, anno: 1997,
pagine: 114 - 119
SICI:
0040-6376(1997)52:2<114:EOCTOD>2.0.ZU;2-D
Fonte:
ISI
Lingua:
ENG
Soggetto:
AIRWAY-RESISTANCE SYNDROME; APNEA HYPOPNEA SYNDROME; NASAL CPAP; LATENCY TEST; IMPAIRMENT; SCALE;
Keywords:
SLEEP APNOEA/HYPOPNOEA SYNDROME; CPAP; PSYCHOMOTOR PERFORMANCE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
26
Recensione:
Indirizzi per estratti:
Citazione:
H.M. Engleman et al., "EFFECT OF CPAP THERAPY ON DAYTIME FUNCTION IN PATIENTS WITH MILD SLEEP APNOEA HYPOPNOEA SYNDROME/", Thorax, 52(2), 1997, pp. 114-119

Abstract

Background - Continuous positive airway pressure (CPAP) is an effective treatment in patients with moderate and severe sleep apnoea/hypopnoea syndrome (SAHS), but the minimum illness severity at which patientsobtain benefit from CPAP is unclear. A study was therefore undertakento investigate whether CPAP improves symptoms and daytime function inpatients with mild SAHS. Methods - Sixteen consecutively recruited patients with mild SAHS (5.0-14.9 apnoeas + hypopnoeas per hour slept and two or more symptoms of SAHS) participated in a prospective placebo controlled randomised crossover trial to assess the effects of CPAP onsymptoms and daytime function. Patients spent four weeks on placebo and four weeks on CPAP, undergoing assessments of sleepiness, symptoms,cognitive performance, and well being on the last day of each treatment. Data from the placebo and CPAP assessments were compared. Results - The mean (SE) objective effective use of CPAP was 2.8 (0.7) hours per night. Significant improvements in symptom score (-1.7 (0.5), p<0.01), mental flexibility (-14 (5) seconds, p=0.02), and depression rating(-1.6 (0.8), p=0.03) on CPAP were observed. However, no significant differences in subjective or objective sleepiness were found. Ten of the 16 patients preferred CPAP and opted to continue with this treatment, although this proportion was non-significant (p>0.4). The eight patients with best CPAP use showed an additional CPAP related improvement in quality of life (-4.4 (1.8), p=0.03). Those who complied better with CPAP therapy also had a higher average microarousal frequency (p<0.01) and apnoea + hypopnoea index (p=0.02) than the poorer compliers. Conclusions - The results of this study provide evidence for improvements in symptoms and daytime function for patients with mild SAHS treatedwith CPAP.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/20 alle ore 09:56:40